Global Endoscopic Submucosal Dissection Market Size Worth USD 542.38 Million By 2032 | CAGR of 5.4%
SPHERICAL INSIGHTS LLP
SPHERICAL INSIGHTS LLP

The Endoscopic Submucosal Dissection Market Size was valued at USD 320.55 Million in 2022 and the Worldwide Endoscopic submucosal Dissection Market Size is expected to reach USD 542.38 Million by 2032, according to a research report published by Spherical Insights & Consulting. Companies Covered: Olympus Corporation, Boston Scientific Corporation, FUJIFILM Holdings Corporation, Sumitomo Bakelite Co. Ltd., Creo Medical PLC, MTW-Endoskopie W.Haag KG, Ovesco Endoscopy AG, KARL STORZ SE & Co. KG, CONMED Corporation, Micro-Tech Endoscopy and Other key vendors.

New York, United States, Nov. 15, 2023 (GLOBE NEWSWIRE) -- The Global Endoscopic Submucosal Dissection Market Size is expected to reach USD 542.38 Million By 2032, at a CAGR of 5.4% during the forecast period 2022 to 2032.

Get a Sample PDF Brochure: https://www.sphericalinsights.com/request-sample/2492

Endoscopic Submucosal Dissection (ESD) is a minimally invasive procedure used for the precise removal of early-stage gastrointestinal tumors or lesions. It involves inserting a specialized endoscope through the mouth or anus to access the affected area. Utilizing electrosurgical devices and techniques, the lesion is dissected and lifted from the submucosal layer in an en-bloc manner. ESD offers advantages like shorter hospital stays, reduced complications, and improved patient outcomes compared to traditional surgery. However, its complexity requires skilled endoscopists. ESD is a valuable option for managing early gastrointestinal neoplasms, providing a less invasive alternative to conventional surgery.

Browse key industry insights spread across 200 pages with 120 Market data tables and figures & charts from the report on the “Global Endoscopic Submucosal Dissection Market Size, Share, and COVID-19 Impact Analysis, By Product (Gastroscopes & Colonoscopes, Knives, Injection Agents, Tissue Retractors, and Graspers/Clips), By Indication (Stomach Cancer, Colan Cancer, and Esophageal Cancer), By End-User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022 – 2032.”         

Buy Now Full Report: https://www.sphericalinsights.com/checkout/2492

The knives segment is expected to grow at a higher CAGR of around 5.7% during the forecast period
Based on the product type, the global endoscopic submucosal dissection market is segmented into gastroscopes & colonoscopes, knives, injection agents, tissue retractors, and graspers/clips. The knives segment in the endoscopic submucosal dissection (ESD) market is anticipated to experience higher growth during the forecast period for several reasons. Technological advancements in ESD knives, such as the development of specialized and innovative devices, are driving the demand for more precise and efficient procedures. These advanced knives offer improved dissection capabilities, enabling better maneuverability and enhanced control during ESD surgeries. Additionally, the increasing prevalence of early-stage gastrointestinal tumors and the growing adoption of minimally invasive treatments like ESD contribute to the rising demand for specialized knives. As a result, the knives segment is expected to witness significant growth in the ESD market.
The esophageal cancer segment is expected to grow at a higher CAGR of around 5.3% during the forecast period
Based on the indication, the global endoscopic submucosal dissection market is segmented into stomach cancer, colan cancer, and esophageal cancer. The esophageal cancer segment in the endoscopic submucosal dissection (ESD) market is projected to experience higher growth during the forecast period due to several factors. Esophageal cancer is a serious and life-threatening condition with a rising incidence globally. ESD offers a minimally invasive treatment option for early-stage esophageal cancer, providing better outcomes and reduced postoperative complications compared to traditional surgical interventions. As awareness of ESD's benefits increases among healthcare professionals and patients, along with advancements in endoscopic technologies and expertise in performing ESD procedures, the demand for ESD as a preferred treatment choice for esophageal cancer management is expected to surge, leading to higher growth in this segment.
Inquire Before Buying This Research Report: https://www.sphericalinsights.com/inquiry-before-buying/2492